Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS

Clinical trial NCT02204020 · WITHDRAWN

Trial details

NCT number: NCT02204020
Sponsor: University of Pittsburgh
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)

Start date: 2015-04-01
Primary completion: 2015-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.